Chen Lizhu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Ipilimumab (N01) Plus Sintilimab and Modified XELOX as Conversion Therapy in Unresectable Locally Advanced Gastric Cancer (NCT07638631) | Chen Lizhu | 2026-06-15 |
Track Chen Lizhu automatically
Every clearance here is in the API, with alerts when new ones post.